Johnson & Johnson to begin human trials for coronavirus vaccine in late July, earlier than expected

J&J said it is committed to the goal of supplying more than one billion doses globally through the course of 2021.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.